195 related articles for article (PubMed ID: 32239692)
21. Nail Psoriasis Treatment: Insights into Current Progress and Future Trends.
Nirbhavane P; Sharma G; Verma S; Jadon RS; Singh B; Katare OP
Crit Rev Ther Drug Carrier Syst; 2020; 37(2):135-159. PubMed ID: 32865903
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual delivery.
Nair AB; Singh K; Shinu P; Harsha S; Al-Dhubiab BE
Drug Dev Ind Pharm; 2013 May; 39(5):807-15. PubMed ID: 23057692
[TBL] [Abstract][Full Text] [Related]
23. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
24. Matrix based system of isotretinoin as nail lacquer to enhance transungal delivery across human nail plate.
Joshi M; Sharma V; Pathak K
Int J Pharm; 2015 Jan; 478(1):268-277. PubMed ID: 25445993
[TBL] [Abstract][Full Text] [Related]
25. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
26. Formulations Based on Natural Ingredients for the Treatment of Nail Diseases.
Tampucci S; Terreni E; Zucchetti E; Burgalassi S; Chetoni P; Monti D
Curr Pharm Des; 2020; 26(5):556-565. PubMed ID: 31969086
[TBL] [Abstract][Full Text] [Related]
27. Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
Abd-Elsalam WH; Abouelatta SM
AAPS PharmSciTech; 2023 Jul; 24(6):150. PubMed ID: 37421509
[TBL] [Abstract][Full Text] [Related]
28. A study on the effect of inorganic salts in transungual drug delivery of terbinafine.
Nair AB; Sammeta SM; Vaka SR; Narasimha Murthy S
J Pharm Pharmacol; 2009 Apr; 61(4):431-7. PubMed ID: 19298688
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.
Vikas A; Rashmin P; Mrunali P; Chavan RB; Kaushik T
AAPS PharmSciTech; 2020 Jan; 21(2):67. PubMed ID: 31938980
[TBL] [Abstract][Full Text] [Related]
30. Emerging topical onychomycosis therapies - quo vadis?
Elkeeb R; Hui X; Murthy N; Maibach HI
Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
[TBL] [Abstract][Full Text] [Related]
31. A systematic approach to the formulation of anti-onychomycotic nail patches.
Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
[TBL] [Abstract][Full Text] [Related]
32. Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.
Cutrín Gómez E; Anguiano Igea S; Delgado-Charro MB; Gómez Amoza JL; Otero Espinar FJ
Eur J Pharm Biopharm; 2018 Jul; 128():48-56. PubMed ID: 29673870
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
34. Management of Nail Psoriasis.
Rigopoulos D; Rompoti N; Gregoriou S
Dermatol Clin; 2021 Apr; 39(2):211-220. PubMed ID: 33745634
[TBL] [Abstract][Full Text] [Related]
35. Tacalcitol ointment for the treatment of nail psoriasis.
Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
[TBL] [Abstract][Full Text] [Related]
36. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
[TBL] [Abstract][Full Text] [Related]
37. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.
Flores FC; Chiu WS; Beck RCR; da Silva CB; Delgado-Charro MB
Int J Pharm; 2018 Jan; 535(1-2):237-244. PubMed ID: 29126904
[TBL] [Abstract][Full Text] [Related]
39. Treatment and management strategies of onychomycosis.
Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
[TBL] [Abstract][Full Text] [Related]
40. Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
Dhamoon RK; Popli H; Gupta M
Pharm Nanotechnol; 2019; 7(1):24-38. PubMed ID: 31092174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
